Last Updated: 16/07/2022
Malaria Vaccine Introduction in Nigeria
Objectives
The objectives of this project are:
- Conduct a Rapid Situation Analysis (RSA) to identify the key factors that influence malaria vaccine demand and new vaccine introduction decisions and priorities, at the National and State levels.
- Building on the RSA, engage relevant global and country stakeholders in a process to develop a Malaria Vaccine Introduction Roadmap for Nigeria
Principal Institution
Principal Investigators / Focal Persons
Partner Institutions
Rationale and Abstract
Nigeria, as Africa’s most populous country and the one with the greatest malaria burden, is key to the region’s future in controlling and, eventually, eliminating this devastating disease. As such, its decisions on whether to adopt and how to use the RTS,S/AS01 malaria vaccine are of critical importance. PATH is undertaking activities to support informed decision-making on malaria vaccine adoption in Nigeria.
Thematic Categories
Date
Feb 2022 — Dec 2022
Funding Details
Project Site
Related Resources
